Omicron Biopharma Supports COVID-19 Vaccine Clinics

Omicron Biopharma Supports COVID-19 Vaccine Clinics

Toronto to ramp up COVID-19 vaccine clinic operations in response to Omicron Group’s support

Toronto, ON — In response to the support of Omicron Biopharma Inc. (TSX-V: OOQ), Toronto’s public health units and the City of Toronto will ramp up COVID-19 vaccine clinic operations in the next few weeks from April 1 to 30 as part of the City’s COVID-19 response.

“We’ve been working with City staff and partners to prepare for the clinic visits while ensuring public safety and social distancing between clients,” said Peter Slaton, CEO of Omicron Biopharma. “We believe that this is a vital role in the COVID-19 response and we’re happy to be a key partner in the fight against this terrible disease.”

In the coming weeks, at Omicron’s Toronto Centre for Infectious Diseases, the City of Toronto will administer COVID-19 vaccines to vulnerable populations. The vaccines will be administered by staff trained by the City of Toronto.

The Omicron Toronto Centre for Infectious Diseases is operated by Omicron Biopharma and is equipped with the latest state of the art vaccine manufacturing equipment and processes to ensure high-quality product for the COVID-19 vaccine clinic.

“We’re pleased that Omicron is supporting this important program,” said Dr. Eileen de Villa, the Mayor’s Chief Medical Officer. “With the increased risk of infection due to COVID-19 and the fact that individuals are at risk of getting serious complications and death, we believe this is the best step to prevent the COVID-19 disease. The clinic will be the first of many to be established in the coming weeks.”

Individuals with flu-like symptoms, including cough, runny nose, fever, and sore throat, will be provided with a COVID-19 vaccine. Health care workers, including doctors, nurses, and

Leave a Comment